Jane Street
CNTA

Jane Street’s Centessa Pharmaceuticals CNTA Stock Holding History

Jane Street’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$771K Sell
19,400
-3,800
-16% -$97.2K ﹤0.01% 7068
2025
Q4 		$580K Sell
23,200
-18,800
-45% -$476K ﹤0.01% 7350
2025
Q3 		$1.02M Buy
+42,000
New +$747K ﹤0.01% 6278

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jane Street's CNTA Position: Q1 2026 in Review

Jane Street reduced its Centessa Pharmaceuticals (CNTA) stake by 91% in Q1 2026, selling an estimated $11.2M and leaving 40,968 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #5476.

Jane Street first reported a position in CNTA in Q2 2022 and has held it in 10 quarters since. The position peaked at $12M in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Jane Street held 40,968 shares of Centessa Pharmaceuticals worth $1.63M as of Q1 2026.
  • Jane Street sold 439,236 Centessa Pharmaceuticals shares in Q1 2026, an estimated $11.2M.
  • Centessa Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5476 holding.
  • Jane Street first reported a position in Centessa Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
  • Jane Street's Centessa Pharmaceuticals position peaked at $12M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.